Shanghai, China

Cheng Luo

This inventor holds 20 USPTO granted patents and 12 published patent applications and 2 EPO patents, primarily in Power Conversion Technology. Top assignees: Eaton Intelligent Power Limited, Cloudminds Robotics Co., Ltd., Chinese Academy of Sciences. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cheng Luo. Retrieved from https://idiyas.com/inventor/cheng-luo-n4yuvh06

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 90.0

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Power Conversion
Dual-Active Bridge
Power Factor Correction
Pulse Width Modulation
Actuator
Harmonic Actuator
Ripple Control
Uninterruptible Power Supply
Histone Acetyltransferase
Bromodomain Inhibitor
Aminomethylenecyclohexane
Triazolopyrimidine
20 patents (USPTO):Explore Patents

Title: Innovator Cheng Luo: Pioneering Advancements in Medicine and Power Conversion

Introduction

Cheng Luo, a prominent inventor based in Shanghai, China, is known for his significant contributions to the fields of biomedicine and power conversion. With an impressive portfolio of 11 patents, Luo has been at the forefront of innovative solutions that address critical challenges in healthcare and energy efficiency.

Latest Patents

Among his latest patents is the invention of a Histone Acetyltransferase (HAT) inhibitor, which offers a new therapeutic approach for treating various conditions related to HAT. This invention includes a diverse range of compounds, each capable of modulating histone acetylation, potentially leading to breakthroughs in cancer and other related diseases.

Another significant patent by Luo is the Multi-active Bridge (MAB) converter and its control method, which presents an innovative design for power conversion devices. The MAB converter utilizes multiple active bridges and integrated transformers to optimize efficiency in converting DC to AC power. This invention utilizes advanced configurations to enhance performance in electrical systems.

Career Highlights

Cheng Luo has made substantial contributions through his associations with leading organizations. He has worked at Wigen Biomedicine Technology (Shanghai) Co., Ltd., where his expertise in biomedicine significantly advanced the company’s research capabilities. Additionally, he has been affiliated with the Chinese Academy of Sciences, collaborating on innovative projects that drive scientific discovery.

Collaborations

Throughout his career, Luo has collaborated with esteemed colleagues such as Hualiang Jiang and Yuanyuan Zhang. These partnerships have fostered a dynamic creative environment, resulting in impactful research and patents that enhance both fields of biomedicine and electrical engineering.

Conclusion

Cheng Luo exemplifies the spirit of innovation through his extensive work in developing new medical treatments and efficient power systems. His 11 patents reflect not only his technical prowess but also his commitment to addressing some of the most pressing challenges in health and technology. As he continues his work, Cheng Luo undoubtedly remains a vital figure in the evolution of these critical domains.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…